DNA Damage Response Drugs Market - Global Outlook and Forecast 2021-2027

March 2021 | 109 pages | ID: D14A86298A40EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of DNA Damage Response Drugs in Global, including the following market information:

Global DNA Damage Response Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global DNA Damage Response Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the DNA Damage Response Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global DNA Damage Response Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global DNA Damage Response Drugs Market Segment Percentages, By Type, 2020 (%)

• Lynparza
• Talzenna
• Zejula
• Rubraca

China DNA Damage Response Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)

China DNA Damage Response Drugs Market Segment Percentages, By Application, 2020 (%)

• Ovarian Cancer
• Breast Cancer
• Pancreatic Cancer
• Prostate Cancer

Global DNA Damage Response Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global DNA Damage Response Drugs Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total DNA Damage Response Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total DNA Damage Response Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• AbbVie Inc
• AstraZeneca
• Bayer
• BeiGene
• Clovis Oncology
• Debiopharm
• Eli Lilly and Company
• GlaxoSmithKline
• Merck
• NMS Group SpA
• Onxeo
• Pfizer
• Repare Therapeutics
• Sierra Oncology
• Zentalis Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 DNA Damage Response Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global DNA Damage Response Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DNA DAMAGE RESPONSE DRUGS OVERALL MARKET SIZE

2.1 Global DNA Damage Response Drugs Market Size: 2021 VS 2027
2.2 Global DNA Damage Response Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top DNA Damage Response Drugs Players in Global Market
3.2 Top Global DNA Damage Response Drugs Companies Ranked by Revenue
3.3 Global DNA Damage Response Drugs Revenue by Companies
3.4 Top 3 and Top 5 DNA Damage Response Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies DNA Damage Response Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 DNA Damage Response Drugs Players in Global Market
  3.6.1 List of Global Tier 1 DNA Damage Response Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 DNA Damage Response Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global DNA Damage Response Drugs Market Size Markets, 2021 & 2027
  4.1.2 Lynparza
  4.1.3 Talzenna
  4.1.4 Zejula
  4.1.5 Rubraca
4.2 By Type - Global DNA Damage Response Drugs Revenue & Forecasts
  4.2.1 By Type - Global DNA Damage Response Drugs Revenue, 2016-2021
  4.2.2 By Type - Global DNA Damage Response Drugs Revenue, 2022-2027
  4.2.3 By Type - Global DNA Damage Response Drugs Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global DNA Damage Response Drugs Market Size, 2021 & 2027
  5.1.2 Ovarian Cancer
  5.1.3 Breast Cancer
  5.1.4 Pancreatic Cancer
  5.1.5 Prostate Cancer
5.2 By Application - Global DNA Damage Response Drugs Revenue & Forecasts
  5.2.1 By Application - Global DNA Damage Response Drugs Revenue, 2016-2021
  5.2.2 By Application - Global DNA Damage Response Drugs Revenue, 2022-2027
  5.2.3 By Application - Global DNA Damage Response Drugs Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global DNA Damage Response Drugs Market Size, 2021 & 2027
6.2 By Region - Global DNA Damage Response Drugs Revenue & Forecasts
  6.2.1 By Region - Global DNA Damage Response Drugs Revenue, 2016-2021
  6.2.2 By Region - Global DNA Damage Response Drugs Revenue, 2022-2027
  6.2.3 By Region - Global DNA Damage Response Drugs Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America DNA Damage Response Drugs Revenue, 2016-2027
  6.3.2 US DNA Damage Response Drugs Market Size, 2016-2027
  6.3.3 Canada DNA Damage Response Drugs Market Size, 2016-2027
  6.3.4 Mexico DNA Damage Response Drugs Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe DNA Damage Response Drugs Revenue, 2016-2027
  6.4.2 Germany DNA Damage Response Drugs Market Size, 2016-2027
  6.4.3 France DNA Damage Response Drugs Market Size, 2016-2027
  6.4.4 U.K. DNA Damage Response Drugs Market Size, 2016-2027
  6.4.5 Italy DNA Damage Response Drugs Market Size, 2016-2027
  6.4.6 Russia DNA Damage Response Drugs Market Size, 2016-2027
  6.4.7 Nordic Countries DNA Damage Response Drugs Market Size, 2016-2027
  6.4.8 Benelux DNA Damage Response Drugs Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia DNA Damage Response Drugs Revenue, 2016-2027
  6.5.2 China DNA Damage Response Drugs Market Size, 2016-2027
  6.5.3 Japan DNA Damage Response Drugs Market Size, 2016-2027
  6.5.4 South Korea DNA Damage Response Drugs Market Size, 2016-2027
  6.5.5 Southeast Asia DNA Damage Response Drugs Market Size, 2016-2027
  6.5.6 India DNA Damage Response Drugs Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America DNA Damage Response Drugs Revenue, 2016-2027
  6.6.2 Brazil DNA Damage Response Drugs Market Size, 2016-2027
  6.6.3 Argentina DNA Damage Response Drugs Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa DNA Damage Response Drugs Revenue, 2016-2027
  6.7.2 Turkey DNA Damage Response Drugs Market Size, 2016-2027
  6.7.3 Israel DNA Damage Response Drugs Market Size, 2016-2027
  6.7.4 Saudi Arabia DNA Damage Response Drugs Market Size, 2016-2027
  6.7.5 UAE DNA Damage Response Drugs Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 AbbVie Inc
  7.1.1 AbbVie Inc Corporate Summary
  7.1.2 AbbVie Inc Business Overview
  7.1.3 AbbVie Inc DNA Damage Response Drugs Major Product Offerings
  7.1.4 AbbVie Inc DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.1.5 AbbVie Inc Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca DNA Damage Response Drugs Major Product Offerings
  7.2.4 AstraZeneca DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.2.5 AstraZeneca Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer DNA Damage Response Drugs Major Product Offerings
  7.3.4 Bayer DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.3.5 Bayer Key News
7.4 BeiGene
  7.4.1 BeiGene Corporate Summary
  7.4.2 BeiGene Business Overview
  7.4.3 BeiGene DNA Damage Response Drugs Major Product Offerings
  7.4.4 BeiGene DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.4.5 BeiGene Key News
7.5 Clovis Oncology
  7.5.1 Clovis Oncology Corporate Summary
  7.5.2 Clovis Oncology Business Overview
  7.5.3 Clovis Oncology DNA Damage Response Drugs Major Product Offerings
  7.5.4 Clovis Oncology DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.5.5 Clovis Oncology Key News
7.6 Debiopharm
  7.6.1 Debiopharm Corporate Summary
  7.6.2 Debiopharm Business Overview
  7.6.3 Debiopharm DNA Damage Response Drugs Major Product Offerings
  7.6.4 Debiopharm DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.6.5 Debiopharm Key News
7.7 Eli Lilly and Company
  7.7.1 Eli Lilly and Company Corporate Summary
  7.7.2 Eli Lilly and Company Business Overview
  7.7.3 Eli Lilly and Company DNA Damage Response Drugs Major Product Offerings
  7.4.4 Eli Lilly and Company DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.7.5 Eli Lilly and Company Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline DNA Damage Response Drugs Major Product Offerings
  7.8.4 GlaxoSmithKline DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.8.5 GlaxoSmithKline Key News
7.9 Merck
  7.9.1 Merck Corporate Summary
  7.9.2 Merck Business Overview
  7.9.3 Merck DNA Damage Response Drugs Major Product Offerings
  7.9.4 Merck DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.9.5 Merck Key News
7.10 NMS Group SpA
  7.10.1 NMS Group SpA Corporate Summary
  7.10.2 NMS Group SpA Business Overview
  7.10.3 NMS Group SpA DNA Damage Response Drugs Major Product Offerings
  7.10.4 NMS Group SpA DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.10.5 NMS Group SpA Key News
7.11 Onxeo
  7.11.1 Onxeo Corporate Summary
  7.11.2 Onxeo Business Overview
  7.11.3 Onxeo DNA Damage Response Drugs Major Product Offerings
  7.11.4 Onxeo DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.11.5 Onxeo Key News
7.12 Pfizer
  7.12.1 Pfizer Corporate Summary
  7.12.2 Pfizer Business Overview
  7.12.3 Pfizer DNA Damage Response Drugs Major Product Offerings
  7.12.4 Pfizer DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.12.5 Pfizer Key News
7.13 Repare Therapeutics
  7.13.1 Repare Therapeutics Corporate Summary
  7.13.2 Repare Therapeutics Business Overview
  7.13.3 Repare Therapeutics DNA Damage Response Drugs Major Product Offerings
  7.13.4 Repare Therapeutics DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.13.5 Repare Therapeutics Key News
7.14 Sierra Oncology
  7.14.1 Sierra Oncology Corporate Summary
  7.14.2 Sierra Oncology Business Overview
  7.14.3 Sierra Oncology DNA Damage Response Drugs Major Product Offerings
  7.14.4 Sierra Oncology DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.14.5 Sierra Oncology Key News
7.15 Zentalis Pharmaceuticals
  7.15.1 Zentalis Pharmaceuticals Corporate Summary
  7.15.2 Zentalis Pharmaceuticals Business Overview
  7.15.3 Zentalis Pharmaceuticals DNA Damage Response Drugs Major Product Offerings
  7.15.4 Zentalis Pharmaceuticals DNA Damage Response Drugs Revenue in Global (2016-2021)
  7.15.5 Zentalis Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. DNA Damage Response Drugs Market Opportunities & Trends in Global Market
Table 2. DNA Damage Response Drugs Market Drivers in Global Market
Table 3. DNA Damage Response Drugs Market Restraints in Global Market
Table 4. Key Players of DNA Damage Response Drugs in Global Market
Table 5. Top DNA Damage Response Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global DNA Damage Response Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global DNA Damage Response Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies DNA Damage Response Drugs Product Type
Table 9. List of Global Tier 1 DNA Damage Response Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 DNA Damage Response Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global DNA Damage Response Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - DNA Damage Response Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - DNA Damage Response Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global DNA Damage Response Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - DNA Damage Response Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - DNA Damage Response Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global DNA Damage Response Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global DNA Damage Response Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global DNA Damage Response Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America DNA Damage Response Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe DNA Damage Response Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia DNA Damage Response Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America DNA Damage Response Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa DNA Damage Response Drugs Revenue, (US$, Mn), 2022-2027
Table 30. AbbVie Inc Corporate Summary
Table 31. AbbVie Inc DNA Damage Response Drugs Product Offerings
Table 32. AbbVie Inc DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca DNA Damage Response Drugs Product Offerings
Table 35. AstraZeneca DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Bayer Corporate Summary
Table 37. Bayer DNA Damage Response Drugs Product Offerings
Table 38. Bayer DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 39. BeiGene Corporate Summary
Table 40. BeiGene DNA Damage Response Drugs Product Offerings
Table 41. BeiGene DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Clovis Oncology Corporate Summary
Table 43. Clovis Oncology DNA Damage Response Drugs Product Offerings
Table 44. Clovis Oncology DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Debiopharm Corporate Summary
Table 46. Debiopharm DNA Damage Response Drugs Product Offerings
Table 47. Debiopharm DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Eli Lilly and Company Corporate Summary
Table 49. Eli Lilly and Company DNA Damage Response Drugs Product Offerings
Table 50. Eli Lilly and Company DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline DNA Damage Response Drugs Product Offerings
Table 53. GlaxoSmithKline DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Merck Corporate Summary
Table 55. Merck DNA Damage Response Drugs Product Offerings
Table 56. Merck DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 57. NMS Group SpA Corporate Summary
Table 58. NMS Group SpA DNA Damage Response Drugs Product Offerings
Table 59. NMS Group SpA DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 60. Onxeo Corporate Summary
Table 61. Onxeo DNA Damage Response Drugs Product Offerings
Table 62. Onxeo DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer DNA Damage Response Drugs Product Offerings
Table 65. Pfizer DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 66. Repare Therapeutics Corporate Summary
Table 67. Repare Therapeutics DNA Damage Response Drugs Product Offerings
Table 68. Repare Therapeutics DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 69. Sierra Oncology Corporate Summary
Table 70. Sierra Oncology DNA Damage Response Drugs Product Offerings
Table 71. Sierra Oncology DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)
Table 72. Zentalis Pharmaceuticals Corporate Summary
Table 73. Zentalis Pharmaceuticals DNA Damage Response Drugs Product Offerings
Table 74. Zentalis Pharmaceuticals DNA Damage Response Drugs Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. DNA Damage Response Drugs Segment by Type
Figure 2. DNA Damage Response Drugs Segment by Application
Figure 3. Global DNA Damage Response Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global DNA Damage Response Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global DNA Damage Response Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by DNA Damage Response Drugs Revenue in 2020
Figure 8. By Type - Global DNA Damage Response Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global DNA Damage Response Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global DNA Damage Response Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America DNA Damage Response Drugs Revenue Market Share, 2016-2027
Figure 12. US DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe DNA Damage Response Drugs Revenue Market Share, 2016-2027
Figure 16. Germany DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia DNA Damage Response Drugs Revenue Market Share, 2016-2027
Figure 24. China DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America DNA Damage Response Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa DNA Damage Response Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE DNA Damage Response Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. AbbVie Inc DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AstraZeneca DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bayer DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BeiGene DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Clovis Oncology DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Debiopharm DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Eli Lilly and Company DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. GlaxoSmithKline DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Merck DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. NMS Group SpA DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Onxeo DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Pfizer DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Repare Therapeutics DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Sierra Oncology DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Zentalis Pharmaceuticals DNA Damage Response Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)